ReviewCureus2022
The Efficacy of Bezlotoxumab in the Prevention of Recurrent Clostridium difficile: A Systematic Review.
Abhay Thandavaram et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ReviewCureus2022
Abhay Thandavaram et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.